Catalyst Wire Dossier Catalyst Wire Dossier

ChangTai Keli

· Nanjing NingQi Medicine Science and Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ChangTai Keli, covering 2015-08-03 to 2015-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients [Phase 2, Phase 3]

See pricing